Potentiation of humoral response to the BNT162b2 vaccine after the third dose in patients with solid cancer

Affiliations

• ¹ Medical Oncology 1 Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy. Electronic address: [email protected].
• ² Microbiology and Virology Unit, Dermatological Clinical Department, IRCCS San Gallicano Dermatological Institute, Rome, Italy.
• ³ Medical Oncology 1 Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
• ⁴ Department of Clinical and Molecular Medicine, Università La Sapienza di Roma, Rome, Italy.
• ⁵ Medical Oncology 1 Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy; Biostatistic Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.